4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B
Zhi, Ying1; Gao, Li-Xin3; Jin, Yi2; Tang, Chun-Lan3; Li, Jing-Ya3; Li, Jia3; Long, Ya-Qiu1
刊名BIOORGANIC & MEDICINAL CHEMISTRY
2014-07-15
卷号22期号:14页码:3670-3683
关键词Protein tyrosine phosphatase 1B inhibitor 4-Quinolone-3-carboxylic acid Bidentate ligand Bioisostere Insulin receptor signaling
ISSN号0968-0896
DOI10.1016/j.bmc.2014.05.028
文献子类Article
英文摘要Protein tyrosine phosphatase 1B is a negative regulator in the insulin and leptin signaling pathways, and has emerged as an attractive target for the treatment of type 2 diabetes and obesity. However, the essential pharmacophore of charged phosphotyrosine or its mimetic confer low selectivity and poor cell permeability. Starting from our previously reported aryl diketoacid-based PTP1B inhibitors, a drug-like scaffold of 4-quinolone-3-carboxylic acid was introduced for the first time as a novel surrogate of phosphotyrosine. An optimal combination of hydrophobic groups installed at C-6, N-1 and C-3 positions of the quinolone motif afforded potent PTP1B inhibitors with low micromolar IC50 values. These 4-quinolone-3-carboxylate based PTP1B inhibitors displayed a 2-10 fold selectivity over a panel of PTP's. Furthermore, the bidentate inhibitors of 4-quinolone-3-carboxylic acids conjugated with aryl diketoacid or salicylic acid were cell permeable and enhanced insulin signaling in CHO/hIR cells. The kinetic studies and molecular modeling suggest that the 4-quinolone-3-carboxylates act as competitive inhibitors by binding to the PTP1B active site in the WPD loop closed conformation. Taken together, our study shows that the 4-quinolone-3-carboxylic acid derivatives exhibit improved pharmacological properties over previously described PTB1B inhibitors and warrant further preclinical studies. (C) 2014 Elsevier Ltd. All rights reserved.
资助项目National Natural Science Foundation of China[81325020] ; National Natural Science Foundation of China[81361120410] ; National Natural Science Foundation of China[81125023] ; National Natural Science Foundation of China[91213303] ; National Natural Science Foundation of China[81123004] ; National Natural Science Foundation of China[21262043]
WOS关键词INSULIN-RECEPTOR ; INTEGRASE INHIBITORS ; BINDING-SITE ; PTP1B ; OBESITY ; MICE ; RESISTANCE ; IDENTIFICATION ; SENSITIVITY ; ADIPOSITY
WOS研究方向Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Chemistry
语种英语
出版者PERGAMON-ELSEVIER SCIENCE LTD
WOS记录号WOS:000337991100010
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/276988]  
专题国家新药筛选中心
药物化学研究室
药物安全性评价中心
通讯作者Li, Jia
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China;
2.Yunnan Univ, Sch Chem Sci & Technol, Kunming 650091, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China;
推荐引用方式
GB/T 7714
Zhi, Ying,Gao, Li-Xin,Jin, Yi,et al. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B[J]. BIOORGANIC & MEDICINAL CHEMISTRY,2014,22(14):3670-3683.
APA Zhi, Ying.,Gao, Li-Xin.,Jin, Yi.,Tang, Chun-Lan.,Li, Jing-Ya.,...&Long, Ya-Qiu.(2014).4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B.BIOORGANIC & MEDICINAL CHEMISTRY,22(14),3670-3683.
MLA Zhi, Ying,et al."4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B".BIOORGANIC & MEDICINAL CHEMISTRY 22.14(2014):3670-3683.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace